Fig. 2From: NIMO-CKD-UK: a real-world, observational study of iron isomaltoside in patients with iron deficiency anaemia and chronic kidney diseaseProbability of no retreatment with IV iron, by IIM dose administered during Course 1. IIM iron isomaltoside, IV intravenous, n number of patients included in the analysisBack to article page